2/18
08:00 am
lixt
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
Medium
Report
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
1/21
10:32 am
lixt
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE [Yahoo! Finance]
Medium
Report
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE [Yahoo! Finance]
1/21
08:00 am
lixt
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
Medium
Report
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
1/20
08:00 am
lixt
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
Medium
Report
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
1/13
08:30 am
lixt
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
Medium
Report
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
12/23
09:02 am
lixt
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial [Yahoo! Finance]
Low
Report
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial [Yahoo! Finance]
12/23
08:00 am
lixt
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
Low
Report
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
12/22
05:36 pm
lixt
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering [Yahoo! Finance]
Low
Report
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering [Yahoo! Finance]
12/22
04:48 pm
lixt
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering
Low
Report
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering
12/18
09:00 am
lixt
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
High
Report
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
11/25
08:30 am
lixt
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
High
Report
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment